Analysis of potential cost-savings after introduction of drug-eluting balloon angioplasty for in-stent restenosis or small vessel disease

Korean Circulation Journal

Volumn 41, Issue 12, 2011, Pages 705-711

  Park, Kyungil ^a   Kim, Tae Eun ^a   Park, Kyung Woo ^a   Kang, Hyun Jae ^a   Koo, Bon Kwon ^a   Kim, Hyo Soo ^a  

^a Seoul National University College of Medicine   (South Korea)

Author keywords

Angioplasty, balloon; Coronary restenosis

Indexed keywords

CLOPIDOGREL; PACLITAXEL;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; COST; COST CONTROL; DRUG ELUTING STENT; FEMALE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RESTENOSIS; REVASCULARIZATION; SOUTH KOREA; STATISTICAL SIGNIFICANCE; STENT THROMBOSIS;

EID: 84862938420     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2011.41.12.705     Document Type: Article

References (22)

1. Stone GW, Ellis SG, Cannon L, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. JAMA 2005;294:1215-23. (Pubitemid 41352109)
2. Iofina E, Haager PK, Radke PW, et al. Sirolimus- and paclitaxel-eluting stents in comparison with balloon angioplasty for treatment of in-stent restenosis. Catheter Cardiovasc Interv 2005;64:28-34. (Pubitemid 40069888)
3. Kastrati A, Mehilli J, von Beckerath N, et al. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA 2005;293:165-71. (Pubitemid 40095867)
4. Virmani R, Guagliumi G, Farb A, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004;109:701-5. (Pubitemid 38222887)
5. Posa A, Hemetsberger R, Petnehazy O, et al. Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries. Coron Artery Dis 2008;19:243-7.
6. Cremers B, Speck U, Kaufels N, et al. Drug-eluting balloon: very short-term exposure and overlapping. Thromb Haemost 2009;101:201-6.
7. Unverdorben M, Vallbracht C, Cremers B, et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009;119:2986-94.
8. Hong SJ, Ahn TH, Kim MH, et al. Comparison of the predictors of cronary restenosis after drug-eluting stent implantation in diabetic and nondiabetic patients. Korean Circ J 2007;37:530-7.
9. Elezi S, Kastrati A, Neumann FJ, Hadamitzky M, Dirschinger J, Schömig A. Vessel size and long-term outcome after coronary stent placement. Circulation 1998;98:1875-80. (Pubitemid 28509283)
10. Unverdorben M, Kleber FX, Heuer H, et al. Treatment of small coronary arteries with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2010;99:165-74.
11. Scheller B, Hehrlein C, Bocksch W, et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2008;97:773-81.
12. Bauters C, Hubert E, Prat A, et al. Predictors of restenosis after coronary stent implantation. J Am Coll Cardiol 1998;31:1291-8. (Pubitemid 28219119)
13. Novack V, Nguyen MC, Rooney M, et al. Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents. Am J Cardiol 2010;106:774-9.
14. Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004;110:810-4. (Pubitemid 39096008)
15. Scheller B, Speck U, Romeike B, et al. Contrast media as carriers for local drug delivery: successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur Heart J 2003;24:1462-7. (Pubitemid 36961837)
16. Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary instent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-24. (Pubitemid 44749319)
17. Lee CW, Park SJ. Predictive factors for restenosis after drug-eluting stent implantation. Korean Circ J 2007;37:97-102.
18. Kuntz RE, Safian RD, Carrozza JP, Fishman RF, Mansour M, Baim DS. The importance of acute luminal diameter in determining restenosis after coronary atherectomy or stenting. Circulation 1992;86:1827-35.
19. Savage MP, Fischman DL, Rake R, et al. Efficacy of coronary stenting versus balloon angioplasty in small coronary arteries: Stent Restenosis Study (STRESS) Investigators. J Am Coll Cardiol 1998;31:307-11. (Pubitemid 28153448)
20. Ardissino D, Cavallini C, Bramucci E, et al. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial. JAMA 2004;292:2727-34. (Pubitemid 39628251)
21. Whang YJ, Kim HS, Kim KM, et al. The efficacy of drug eluting stents on restenosis reduction in small coronary arteries. Korean Circ J 2006;36:450-7.
22. Cortese B, Micheli A, Picchi A, Coppolaro A, et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial: the PICCOLETO Study. Heart 2010;96:1291-6.